“Potential of Flavonoid Compounds from Etlingera elatior against Estrogen Receptor Alpha (ER+) as an Anti-Breast Cancer in Silico”, J. Trop. Pharm. Chem, pp. 31–39, Oct. 2025, doi: 10.30872/jtpc.v9i1.289.